Marco Ophthalmic competitors

Timothy 'Tim' Damadian is a President/CEO at FONAR CORP. He has worked as President at Health Mgmt Corp of America, Director:Manufacturing at FONAR CORP, and VP:Operations at FONAR CORP. Timothy attended University of Tennessee.

David J. Endicott is the CEO of Alcon, a member of its Board of Directors, and leads the Alcon Executive Committee. He joined Alcon in July of 2016 as Chief Operating Officer. Prior to Alcon, Mr. Endicott was President of Hospira Infusion Systems, a Pfizer company. During his tenure there, he led Hospira’s medical device business through a turnaround, carve-out, and eventual sale. Critical to the turnaround, he advanced the company’s product pipeline, returned its products to market from quality disruptions and accelerated global growth. Before joining Hospira, David served as an officer and executive committee member of Allergan where he spent more than 25 years of his career in leadership roles across Europe, Asia, Latin America and the US. He accelerated Allergan’s international growth and successfully built new markets focused on medical specialties in the areas of ophthalmology, plastic surgery, dermatology and aesthetic medicine. He currently serves on the Board of Directors of AdvaMed, and has previously served on the Boards of Zeltiq (NASDAQ: ZLTQ), and Orexigen (NASDAQ: OREX). David holds an undergraduate degree in Chemistry from Whitman College, an MBA from the University of Southern California, and is a graduate of the Advanced Management Program at the Harvard Business School.

Experienced public and private equity CEO/President with a strong track record of building value for technology and healthcare businesses located in North America, Asia, and Europe. Led successful mergers and acquisitions (M&A) totaling over $1 billion in global transaction value within the medical device and vision care markets. Skilled in Executive Office, C-Suite Management, Board Management, Mergers & Acquisitions, Corporate Development, Corporate Strategy, Business Operations, and Sales Management. CEO/President/Representative Director experience in United States, South Korea, Singapore, Colombia, United Kingdom, and Mexico including full P&L responsibility.Master of Business Administration (MBA) from Duke University - The Fuqua School of Business and a Bachelor of Science (BS) in Physics from the United States Naval Academy.

Sami Levi works at ISENSIX and a CEO at Aquatec Water System Inc and CEO/CFO at ISENSIX and is based in Irvine, California. He has worked as President at Sigma Medical Imaging Inc and Dir:Mergers & Acquisitions at Fairchild. Sami attended The Wharton School between 1986 and 1988, University of Pennsylvania between 1983 and 1986, and Robert College.